这是一篇来自已证抗体库的有关
人类 PAK3的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PAK3 抗体。
PAK3 同义词: ARA; MRX30; MRX47; OPHN3; PAK-3; PAK3beta; bPAK; beta-PAK; serine/threonine-protein kinase PAK 3; adriamycin resistance-associated; oligophrenin-3; p21 (CDKN1A)-activated kinase 3; p21 protein (Cdc42/Rac)-activated kinase 3
赛默飞世尔
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Biosource, 44-940G)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 st1). Nat Commun (2016) ncbi |
兔 多克隆 | - 免疫细胞化学; African green monkey; 1:150; 图 s8
| 赛默飞世尔 PAK3抗体(生活技术, 44940G)被用于被用于免疫细胞化学在African green monkey样品上浓度为1:150 (图 s8). Nat Commun (2016) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, 44940G)被用于被用于免疫印迹在人类样品上. Sci Adv (2015) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, 44940)被用于被用于免疫印迹在大鼠样品上浓度为1:1000. J Neurosci (2015) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, 44940G)被用于被用于免疫印迹在人类样品上 (图 4). Oncotarget (2015) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, 44940G)被用于被用于免疫印迹在小鼠样品上浓度为1:500. Neuropsychopharmacology (2014) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, 44?C942G)被用于被用于免疫细胞化学在人类样品上浓度为1:100 (图 1). PLoS ONE (2013) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, #44940G, lot #980627A)被用于被用于免疫印迹在小鼠样品上 (图 4). Development (2013) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, 44-940G)被用于被用于免疫印迹在小鼠样品上 (图 3). Mol Neurobiol (2012) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Invitrogen, 44-940G)被用于被用于免疫组化在小鼠样品上浓度为1:100 (图 3). J Neurosci (2010) ncbi |
兔 多克隆 | - 免疫组化-石蜡切片; 小鼠; 1:50; 图 1
- 免疫组化-石蜡切片; 人类; 1:50; 图 6
| 赛默飞世尔 PAK3抗体(Biosource, 44-940G)被用于被用于免疫组化-石蜡切片在小鼠样品上浓度为1:50 (图 1) 和 被用于免疫组化-石蜡切片在人类样品上浓度为1:50 (图 6). J Neurochem (2008) ncbi |
兔 多克隆 | | 赛默飞世尔 PAK3抗体(Biosource, 44-940G)被用于. J Neurosci (2007) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(A-6) | | 圣克鲁斯生物技术 PAK3抗体(Santa Cruz, sc-166887)被用于被用于免疫印迹在小鼠样品上 (图 5D). elife (2017) ncbi |
小鼠 单克隆(D-8) | - 免疫组化; 人类; 图 2a
- 免疫印迹; 人类; 图 3b
| 圣克鲁斯生物技术 PAK3抗体(Santa Cruz Biotechnology, sc-166174)被用于被用于免疫组化在人类样品上 (图 2a) 和 被用于免疫印迹在人类样品上 (图 3b). Oncotarget (2016) ncbi |
小鼠 单克隆(A-6) | | 圣克鲁斯生物技术 PAK3抗体(Santa Cruz, sc-166887)被用于被用于免疫印迹在人类样品上浓度为1:400. PLoS ONE (2016) ncbi |
小鼠 单克隆(A-6) | - 免疫沉淀; 人类; 图 6
- 免疫印迹; 人类; 图 5
| 圣克鲁斯生物技术 PAK3抗体(Santa Cruz Biotechnologies, sc-166887)被用于被用于免疫沉淀在人类样品上 (图 6) 和 被用于免疫印迹在人类样品上 (图 5). Blood (2015) ncbi |
安迪生物R&D
羊 多克隆 | - 免疫组化-石蜡切片; 仓鼠; 1:80
- 免疫细胞化学; 仓鼠; 1:50
- 免疫印迹; 仓鼠
| 安迪生物R&D PAK3抗体(R&D Systems, AF6897)被用于被用于免疫组化-石蜡切片在仓鼠样品上浓度为1:80, 被用于免疫细胞化学在仓鼠样品上浓度为1:50 和 被用于免疫印迹在仓鼠样品上. Med Microbiol Immunol (2014) ncbi |
赛信通(上海)生物试剂有限公司
兔 多克隆 | | 赛信通(上海)生物试剂有限公司 PAK3抗体(Cell Signalling, 2609)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 s8). Nat Commun (2016) ncbi |
兔 多克隆 | - 免疫沉淀; 小鼠; 图 1
- 免疫印迹; 小鼠; 1:1000; 图 1
| 赛信通(上海)生物试剂有限公司 PAK3抗体(Cell Signaling, 2609)被用于被用于免疫沉淀在小鼠样品上 (图 1) 和 被用于免疫印迹在小鼠样品上浓度为1:1000 (图 1). Nat Commun (2015) ncbi |
兔 多克隆 | | 赛信通(上海)生物试剂有限公司 PAK3抗体(Cell Signaling Technology, 2609)被用于被用于免疫印迹在小鼠样品上. Oncotarget (2015) ncbi |
Jeannot P, Nowosad A, Perchey R, Callot C, Bennana E, Katsube T,
et al. p27Kip1 promotes invadopodia turnover and invasion through the regulation of the PAK1/Cortactin pathway. elife. 2017;6:
pubmed 出版商
Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A,
et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852
pubmed 出版商
Martin K, Pritchett J, Llewellyn J, Mullan A, Athwal V, Dobie R,
et al. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis. Nat Commun. 2016;7:12502
pubmed 出版商
Yuan W, Guo Y, Li X, Deng M, Shen Z, Bo C,
et al. MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway. Oncotarget. 2016;7:60230-60244
pubmed 出版商
Reinhard J, Kriz A, Galic M, Angliker N, Rajalu M, Vogt K,
et al. The calcium sensor Copine-6 regulates spine structural plasticity and learning and memory. Nat Commun. 2016;7:11613
pubmed 出版商
Wang Y, Gratzke C, Tamalunas A, Wiemer N, Ciotkowska A, Rutz B,
et al. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate. PLoS ONE. 2016;11:e0153312
pubmed 出版商
Hahn C, Scott D, Xu X, Roda M, Payne G, Wells J,
et al. The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability. Sci Adv. 2015;1:
pubmed
Singh N, Kotla S, Dyukova E, Traylor J, Orr A, Chernoff J,
et al. Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice. Nat Commun. 2015;6:7450
pubmed 出版商
Briz V, Zhu G, Wang Y, Liu Y, Avetisyan M, Bi X,
et al. Activity-dependent rapid local RhoA synthesis is required for hippocampal synaptic plasticity. J Neurosci. 2015;35:2269-82
pubmed 出版商
Chow H, Dong B, Duron S, Campbell D, Ong C, Hoeflich K,
et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6:1981-94
pubmed
Badolia R, Manne B, Dangelmaier C, Chernoff J, Kunapuli S. Gq-mediated Akt translocation to the membrane: a novel PIP3-independent mechanism in platelets. Blood. 2015;125:175-84
pubmed 出版商
Meng G, Tian C, Wang H, Xu Y, Zhang B, Shi Q,
et al. Remarkable reductions of PAKs in the brain tissues of scrapie-infected rodent possibly linked closely with neuron loss. Med Microbiol Immunol. 2014;203:291-302
pubmed 出版商
De Filippis B, Nativio P, Fabbri A, Ricceri L, Adriani W, Lacivita E,
et al. Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome. Neuropsychopharmacology. 2014;39:2506-18
pubmed 出版商
Itakura A, Aslan J, Kusanto B, Phillips K, Porter J, Newton P,
et al. p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophils. PLoS ONE. 2013;8:e73063
pubmed 出版商
Sipe C, Liu L, Lee J, Grimsley Myers C, Lu X. Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization. Development. 2013;140:1785-95
pubmed 出版商
Jafari M, Seese R, Babayan A, Gall C, Lauterborn J. Glucocorticoid receptors are localized to dendritic spines and influence local actin signaling. Mol Neurobiol. 2012;46:304-15
pubmed 出版商
Chen L, Rex C, Babayan A, Kramar E, Lynch G, Gall C,
et al. Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J Neurosci. 2010;30:10977-84
pubmed 出版商
Nguyen T, Galvan V, Huang W, Banwait S, Tang H, Zhang J,
et al. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem. 2008;104:1065-80
pubmed
Chen L, Rex C, Casale M, Gall C, Lynch G. Changes in synaptic morphology accompany actin signaling during LTP. J Neurosci. 2007;27:5363-72
pubmed